Seer, Inc.

Healthcare · Biotechnology · United States

Last price 1.94 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 107.42M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company also offers ...